SYSTEMIC SCLEROSIS PATIENTS EXHIBIT AN INCREASED FREQUENCY OF T CELLS AND NK CELLS WITH EFFECTOR/CYTOTOXIC PHENOTYPE.

被引:0
|
作者
Carvalheiro, Tiago [1 ]
Andrade, Angela [2 ]
Lemos, Magda [2 ]
Santiago, Mariana Galante [3 ]
Silva, Claudia [4 ]
Salvador, Maria Joao [3 ]
Pereira da Silva, Jose Antonio [3 ]
Paiva, Artur [1 ,2 ]
机构
[1] Portuguese Inst Blood & Transplantat, Blood & Transplantat Ctr Coimbra, Coimbra, Portugal
[2] Coll Hlth Technol Coimbra, Coimbra, Portugal
[3] Univ Hosp Ctr Coimbra, Rheumatol Dept, Coimbra, Portugal
[4] Univ Aveiro, P-3800 Aveiro, Portugal
关键词
D O I
10.1136/annrheumdis-2013-205124.118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A3.25
引用
收藏
页码:A52 / A52
页数:1
相关论文
共 50 条
  • [31] Clonal T cells in the blood of patients with systemic sclerosis
    Marie, I
    Cordel, N
    Lenormand, B
    Hellot, MF
    Levesque, H
    Courtois, H
    Joly, P
    ARCHIVES OF DERMATOLOGY, 2005, 141 (01) : 88 - 89
  • [32] T-CELL PHENOTYPE AND INTRACELLULAR CYTOKINE-PRODUCTION IN T-CELLS IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Klein, M.
    Almanzar, G.
    Hoefner, K.
    Schmalzing, M.
    Kleinert, S.
    Tony, H. -P.
    Benoit, S.
    Hamm, H.
    Goebeler, M.
    Prelog, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 830 - 831
  • [33] Reduced circulating natural killer T cells and γ/δ T cells in patients with systemic sclerosis
    Riccieri, V
    Parisi, G
    Spadaro, A
    Scrivo, R
    Barone, F
    Moretti, T
    Bernardini, G
    Strom, R
    Taccari, E
    Valesini, G
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (02) : 283 - 286
  • [34] Trephine biopsies are enriched for activated T/NK cells and cytotoxic T cells
    Dean, J
    McCarthy, D
    Golden-Mason, L
    O'Farrelly, C
    IMMUNOLOGY LETTERS, 2005, 99 (01) : 94 - 102
  • [35] INHIBITION OF EFFECTOR B CELLS BY IBRUTINIB IN SYSTEMIC SCLEROSIS
    Einhaus, J.
    Pecher, A. C.
    Asteriti, E.
    Schmid, H.
    Secker, K. A.
    Duerr-Stoerzer, S.
    Keppeler, H.
    Klein, R.
    Schneidawind, C.
    Henes, J.
    Schneidawind, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1313 - 1314
  • [36] Inhibition of effector B cells by ibrutinib in systemic sclerosis
    Jakob Einhaus
    Ann-Christin Pecher
    Elisa Asteriti
    Hannes Schmid
    Kathy-Ann Secker
    Silke Duerr-Stoerzer
    Hildegard Keppeler
    Reinhild Klein
    Corina Schneidawind
    Joerg Henes
    Dominik Schneidawind
    Arthritis Research & Therapy, 22
  • [37] Inhibition of effector B cells by ibrutinib in systemic sclerosis
    Einhaus, Jakob
    Pecher, Ann-Christin
    Asteriti, Elisa
    Schmid, Hannes
    Secker, Kathy-Ann
    Duerr-Stoerzer, Silke
    Keppeler, Hildegard
    Klein, Reinhild
    Schneidawind, Corina
    Henes, Joerg
    Schneidawind, Dominik
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [38] DIFFERENTIAL EFFECT OF CYTOTOXIC MAINTENANCE THERAPY ON T CELLS, TREGS AND NK CELLS IN AML PATIENTS
    Lorenz, R.
    Lichtenegger, F.
    Palluch, P.
    Hoffmueller, U.
    Braess, J.
    Hiddemann, W.
    Beck, B.
    Subklewe, M.
    HAEMATOLOGICA, 2012, 97 : 261 - 261
  • [39] CD4 T cells exhibit an effector phenotype and transfer disease in murine alopecia areata
    Connell, S. J.
    Crotts, S.
    Christy, P.
    Lensing, M.
    Jabbari, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S11 - S11
  • [40] Interleukin-21 maintains T cells in a naive phenotype.
    Ferrari-Lacraz, S
    Foster, DC
    Chicheportiche, R
    CLINICAL IMMUNOLOGY, 2005, 115 : S207 - S207